Lucia Faccio Sofinnova's guest appearances

Lucia Faccio Sofinnova

Empowered Patient Podcast

Mark Allen

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

Robin Zander

OwlTail

Lucia Faccio, Partner for the Sofinnova Telethon Fund at Sofinnova Partners talks about the recent creation of the Sofinnova Telethon Fund in Italy dedicated to early-stage investments in biotechnology companies that are addressing unmet medical needs of those suffering from rare and genetic diseases.  Lucia is particularly enthusiastic about a recent investment in Genespire, company with a game changing technology providing a platform that is a lentiviral gene therapy for treatment of metabolic diseases and another gene editing platform with a focus on treating primary immunodeficiencies. #SofinnovaPartners #Biotech #geneticdiseases #Funding SofinnovaPartners.com Download the transcript here

Lucia Faccio, Partner for the Sofinnova Telethon Fund at Sofinnova Partners talks about the recent creation of the Sofinnova Telethon Fund in Italy dedicated to early-stage investments in biotechnology companies that are addressing unmet medical needs of those suffering from rare and genetic diseases.  Lucia is particularly enthusiastic about a recent investment in Genespire, company with a game changing technology providing a platform that is a lentiviral gene therapy for treatment of metabolic diseases and another gene editing platform with a focus on treating primary immunodeficiencies. #SofinnovaPartners #Biotech #geneticdiseases #Funding <a href="http://sofinnovapartners.com" rel="noopener nofollow" target="_blank">SofinnovaPartners.com</a> <a href="http://empoweredpatientradio.com/investment-strategy-aims-to-accelerate-transition-of-gene-therapy-from-pre-clinical-to-clinical-stage-with-lucia-faccio-sofinnova-partners-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a>

Investment Strategy Aims to Accelerate Transition of Gene Therapy from Pre-clinical to Clinical Stage With Lucia Faccio Sofinnova Partners